Irbesartan Hexal (Irbesartan)

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors. This inhibition prevents vasoconstriction and aldosterone release, leading to relaxed blood vessels, reduced sodium and water retention, and ultimately lower blood pressure and decreased strain on the kidneys.

The appropriate dose of Irbesartan Hexal is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other concurrent medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Irbesartan is generally contraindicated during pregnancy because it may cause fetal harm, especially in the second and third trimesters. Limited data are available for breastfeeding; therefore, the drug should be used only if the potential benefit outweighs the risk, under medical supervision.

To order Irbesartan Hexal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the angiotensin II receptor blocker (ARB) class, offering similar blood‑pressure‑lowering efficacy to ACE inhibitors but with a lower incidence of cough. Compared with calcium‑channel blockers or diuretics, ARBs provide a distinct mechanism that may be preferred in patients with renal concerns or ACE‑inhibitor intolerance.

Irbesartan Hexal should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Irbesartan Hexal is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider and not crush or split the tablet unless instructed.

Serious risks include angioedema (swelling of the face, lips, tongue or throat), severe hyperkalemia, acute renal failure, and rare cases of hepatic injury. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden loss of kidney function, or signs of liver problems.

Irbesartan Hexal should not be used by individuals with known hypersensitivity to irbesartan or any component of the formulation, pregnant women, or patients with severe hepatic impairment. Caution is also advised for those with advanced renal disease or uncontrolled hyperkalemia.